Evidence map›Paper›PMID 38058983›Full record

ArticleStem cells international2023

Immunization with Embryonic Stem Cells/Induced Pluripotent Stem Cells Induces Effective Immunity against Ovarian Tumor-Initiating Cells in Mice.

Fengsheng Yu, Zujuan Zhang, Xiaohong Chang, Xue Ye, Hongyan Cheng, Yi Li, Heng Cui

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fengsheng YuCenter of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China.ORCID https://orcid.org/0000-0002-3227-8627
Zujuan ZhangCenter of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China.
Xiaohong ChangCenter of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China.
Xue YeCenter of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China.
Hongyan ChengCenter of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China.
Yi LiCenter of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China.ORCID https://orcid.org/0000-0003-1998-2545
Heng CuiCenter of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China.ORCID https://orcid.org/0000-0002-7253-0575
Peking University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs) express pluripotent markers and share many features with normal pluripotent stem cells. It is possible that immunity induced by embryonic stem cells (ESCs) and induced pluripotent stem cells- (IPSCs-) based vaccines may selectively target CSCs. In our study, cells expressing the pluripotent marker CD133 in the murine ovarian cancer cell-line ID8 were isolated and identified as CSCs. We investigated the preventive efficacy of ESCs and IPSCs-based vaccines against the development of ovarian cancer

Identifiers

PMID38058983
PMCPMC10696476
OpenAlexW4389039258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.